PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
243.6K views | +94 today
Follow

NTIC : Comment promouvoir leur usage chez les médecins et les professionnels de santé 

From www.santelog.com

Recueillir, stocker, traiter et partager l'information et notamment les données « patients » par voie électronique fait partie des enjeux et des défis prioritaires à relever dans nos systèmes de santé.

No comment yet.

Les médecins attendent beaucoup des technologies 

From www.itnumeric.com

Le géant japonais de l’électronique Epson vient de sonder sept mille ‘’professionnels de la santé’’ en Europe.
No comment yet.

What kind of digital health tools will improve patient engagement?

From medcitynews.com

When you’re sick or require medical attention, you need to be focused. But emotions and physical limitations can impede the ability of a patient or their family to understand and retain important details, such as instructions for surgical prep or aftercare, which can have a significant impact on a patient’s health outcomes. In fact, an estimated 50 percent of patients don’t experience optimal clinical outcomes because they don’t correctly follow their physician’s instructions.
Aristide Adjinacou's curator insight, March 16, 3:17 AM
Patient engagement is 50% of the treatment so let 's  do what needs to be done in that area

Le laboratoire pharmaceutique Janssen lance son fonds de dotation #hcsmeufr

From www.carenews.com

Le groupe pharmaceutique Janssen crée son fonds de dotation. Des appels à projets seront bientôt lancés pour récompenser les initiatives qui contribuent à…
No comment yet.

Digital Health Tech Takes Off in Clinical Trials and Pharmaceuticals

From insights.samsung.com

Digital Health in Clinical Trials

In a new survey on how digital health devices and data impact clinical trials, digital health technology vendor Validic reported:

Sixty percent of respondents said they have used digital health technology to conduct clinical trials.
Ninety-seven percent of respondents said they will increase their use of digital technologies in clinical trials in the next five years.
Mobile apps and in-home clinical-grade devices are currently the most commonly used devices in clinical drug trials, but wearable activity trackers and sensors will be the focus of future use.
Seventy percent of respondents said patient-generated health data (PGHD) could have the greatest impact on improving treatments for chronically ill populations.

Getting Social in the Real World | Thought leadership and innovation for the Pharmaceutical Industry - EyeforPharma

From social.eyeforpharma.com

Although it would be facetious to say that social media has reached a tipping point into ubiquity, it is only relatively recently that it has been used by pharma to collect and analyze patient data. This use of social media may only be in its infancy but as a quick and inexpensive way to gather large-scale, real-world data it is growing rapidly.
No comment yet.

Direct-to-Consumer #Pharma Drug Ad Spending at an All-Time High

From www.mmm-online.com

Spending on direct-to-consumer pharmaceutical ads rose 9% to $5.6 billion in 2016 [see note below], in part fueled by a 16% boost in spending from Bristol-Myers Squibb, according to data from Nielsen.

Pfizer and Bristol-Myers Squibb again took the two top spots among drugmakers, spending $1.1 billion and $458 million, respectively, on DTC ads. AbbVie, Eli Lilly, and Allergan rounded out the top five DTC spenders. The Nielsen figures include business to business, outdoor, cinema, television, magazine, newspaper, and radio media spend, but not digital.

Newer brands to the top 20 list in 2016 include Novartis' heart-failure drug Entresto ($122 million), Novo Nordisk's diabetes treatment Victoza ($128 million), Celgene's psoriasis drug Otezla ($96 million), and Eli Lilly's diabetes drug Trulicity ($184 million).

The Celgene ad is under scrutiny by regulators. The drugmaker received an untitled letter from the FDA's Office of Prescription Drug Promotion last year over its DTC ad for Otezla, which said the ad's use of loud music and attention-grabbing visuals downplayed the risk information presented therein (here).

When broken down by channel, pharma companies spent less on cinema, newspaper, and radio media last year but sharply increased their investment in outdoor media by 552%. Business to business, television, and magazine media spend also grew, by 31%, 11%, and 6%, respectively.

Pharma Guy's curator insight, March 6, 10:33 AM

Note: The 2016 data comes from Neilsen. The data in my chart for 2014 and 2015 comes from Kantar Media, which generally reports slightly higher numbers. In 2015, for example, Kantar estimated the DTC spend to be $5.4 billion whereas Neilsen estimated it to be around $5.2. Whatever the source, it is clear that DTC ad spending is at an all-time high. I included data from AARP regarding its estimate of % price increase for drugs used by older Americans.

Sanofi lance des essais cliniques "numériques" à distance

From www.leparisien.fr

Le groupe pharmaceutique français Sanofi a annoncé jeudi le lancement d'essais cliniques "numériques" permettant en particulier de suivre les participants à distance, en partenariat avec la société californienne Science 37.
Cette initiative vise à décentraliser et dématérialiser, grâce au numérique, la conduite (des) essais cliniques. La nouvelle méthode s'appuiera sur les technologies mobiles et la télémédecine.

No comment yet.

Can patient portals bridge the digital divide?

From insight.athenahealth.com

Patient portals are an easy way for patients and physicians to stay in touch in between visits. That's why they are a key tool for building patient loyalty, reducing staff workloads, and increasing revenues and patient engagement.
They could also be an aid for managing population health — but only if patients in need of services actually use their portal accounts.
Across cities and towns, that's beginning to happen. Of 4.8 million urban patients on the athenahealth network who had doctors' visits between January and August 2016, 33 percent were registered on their physicians' portals.
But outside of urban areas, it's a different story: Just 18 percent of rural patients across the network use a portal.
No comment yet.

Takeda Tests Apple Watch App for Patients with Major Depressive Disorder (MDD)

From www.pmlive.com

Working with UK firm Cambridge Cognition the company is piloting the app to monitor and assess cognitive function in patients with MDD, which affects around 350 million around the world.

 

Nicole Mowad-Nassar, vice president of external partnerships at Takeda Pharmaceuticals USA, said: “This collaboration is part of our strategy to embrace new technology to better understand the patient experience and assist healthcare professionals in creating improved patient care pathways.”

 

The small 30-patient trials of adults who have been prescribed an antidepressant will evaluate the app's feasibility and compliance, and aims to understand how a wearable's measures of mood and cognition compare to traditional neuropsychological testing and patient reported assessments.

Pharma Guy's curator insight, March 2, 1:44 PM

Further Reading:

Prabhas Buddu's comment, March 2, 2:06 PM
http://techfeastpro.com/news/nokia-icon-back-nokia-3310-nokia-3-nokia-5/

2016 was record year for generics, Top 10 drugs going off-patent in 2017, Soon, no more ED ads!

From www.linkedin.com

Welcome to the February 28, 2017, edition of Pharma Industry News Update (aka PinUp), which is published every Tuesday and Friday as part of the Pharma Marketing News subscription service. PinUp presents selected content of topical interest from a variety of sources. View the Web version of this issue here: http://bit.ly/PINUP022817  

 

Articles in this issue:

 

Further Reading:

 

About Pharma Industry News Update

The Pharma Industry News Update (aka PinUp) is published every Tuesday and Friday as part of the Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources. If you'd like to receive this newsletter, subscribe here.

No comment yet.

Drug Developers Embrace the Rising Prominence - and Influence - of Patient Advocacy

From www.appliedclinicaltrialsonline.com

Thirty years ago, it was a much different world. Patient advocacy groups were far fewer in number and impact, their work relegated largely to promoting awareness, raising money, and helping drug companies promote clinical trials. It wasn’t until a not-so-rare disease — the HIV and AIDS epidemic of the 1980s — that advocates took on a more substantial role. In particular, 1988 stands out as the year that the FDA began working with AIDS activists and awakened to the power of patient engagement.
No comment yet.

La France reste un pays toujours attractif pour les essais cliniques, malgré une mauvaise réputation - L'Usine Santé

From www.usinenouvelle.com

Alors que les prescripteurs d'essais cliniques n'ont pas une très bonne perception de la France, l'Hexagone reste attractif pour les essais cliniques et... - L'Usine Santé
No comment yet.

Podcast: Pharma YouTube - Successful Use of Online Video to Support Patients

From www.talk.pharma-mkting.com

Pharmaceutical marketers have a wealth of experience producing videos for direct-to-consumer (DTC) advertising (in the U.S.) and disease-awareness piblic service messages worldwide. It's no surprise, therefore, that the Dose of Digital's Pharma and Healthcare Social Media Wiki includes dozens of pharma YouTube channels, or what I like to call "YouPharma".

 

The Johnson & Johson family of companies, which includes Janssen UK, have been the leaders in launching branded and unbranded YouTube channels. This show features two of the best examples of that. Gary Monk is the person responsible for Janssen-Cilag's "Living with ADHD" YouTube site, which features a video is entitled "ADHD: A day in the life by Janssen-Cilag Ltd." Rob Halper is the person who single-handedly maintains the J&J Health Channel on YouTube, which is a non-branded site with the goal of presenting a better understanding of health and health care issues.

 

 

Questions/Topics Discussed

 

  • Describe your YouTube campaign/channel. Who is the intended audience(s)?
  • How did you get internal buy in for your digital video campaign?
  • How do you define "engagement" with patients via your YouTube channel? Do you allow comments?
  • What's your measure(s) of success?

 

Listen here.

No comment yet.

Pharma Marketing Managers Need To Regain Control Of Their CX By Investing In Measurement Methods

From dt-associates.com

Marketing managers at large pharmaceutical companies are currently unable to determine how well-received their digital initiatives are by their intended target audience—their customers.
No comment yet.

#DIGITALCSP présente sa solution IDPLUG #serialisation #pharma #medicament #hcsmeufr #esante

From pharmageek.fr

Si l’étiquette apposée est assortie d’un RFID/N.F.C, il devient alors possible de continuer la communication avec la boîte, de regrouper l’information de la boite dans le colis et du colis dans la palette… Il devient surtout possible de connaitre en temps réel le positionnement géographique de la palette et d’assurer un tracking total et sécurisé.
No comment yet.

Pharmaceutical companies and digital health startups: It’s time to get together #hcsmeufr

From www.mobihealthnews.com

About the author: Naomi Fried, PhD (@NaomiFried), is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation infrastructure consulting to healthcare stakeholders including pharma companies and providers.
No comment yet.

Livongo to offer Voluntis’ Insulia for type 2 diabetes to improve medication adherence

From www.pharmabiz.com

Livongo to offer Voluntis’ Insulia for type 2 diabetes to improve medication adherence
No comment yet.

YESITIS CONNECTE LES ETIQUETTES EN SERIE #SERIALISATION #PHARMA #hcsmeufr

From pharmageek.fr

Yesitis connecte les étiquettes en série : RFID et NFC - au coeur du médicament connecté pour apporter de nouveaux services et de la sécurité

No comment yet.

Le digital au service de la #SERIALISATION du médicament et de la #supplychain #pharma

From www.linkedin.com

C.S.P. Centre Spécialités Pharmaceutiques, leader dépositaire pharmaceutique, a lancé DIGITAL CSP, plateforme de service numérique, pour accompagner
No comment yet.